文献速递流行病学与生物统计真实世界研究与卫生经济

健康生活方式行为、中介生物标志物与2型糖尿病患者微血管并发症风险:一项队列研究

Healthy lifestyle behaviors, mediating biomarkers, and risk of microvascular complications among individuals with type 2 diabetes: A cohort study.
PubMed 文献 · PLoS Med · 2023-01-10

该回顾性队列研究纳入英国生物银行15104例基线无大血管和微血管并发症的2型糖尿病患者,评估综合健康生活方式行为与微血管并发症风险的关联。中位随访8.1年期间,发生1296例复合微血管并发症。坚持4至5种低风险生活方式行为者相比0至1种者,复合微血管并发症风险显著降低(HR 0.54,95%CI 0.43-0.68)。白蛋白、高密度脂蛋白胆固醇、甘油三酯、载脂蛋白A、C反应蛋白和糖化血红蛋白共同解释了23.20%的关联。

要点

  • 坚持4至5种低风险生活方式行为与2型糖尿病微血管并发症风险降低相关。
  • 复合微血管并发症的风险比(95%CI)为0.54(0.43,0.68)。
  • 白蛋白、高密度脂蛋白胆固醇、甘油三酯、载脂蛋白A、C反应蛋白和糖化血红蛋白共同解释23.20%的关联。

核心结论

  • 坚持综合健康生活方式行为与2型糖尿病患者微血管并发症风险显著降低相关,且该有利关联部分通过改善血糖控制、全身炎症、肝功能和血脂谱的生物标志物介导。

研究设计与样本

  • 回顾性队列研究,纳入英国生物银行15104例基线(2006年至2010年)无大血管和微血管并发症的2型糖尿病患者。

主要发现

  • 中位随访8.1年期间,发生1296例复合微血管并发症,包括558例糖尿病视网膜病变、625例糖尿病肾病和315例糖尿病神经病变,部分患者同时存在2或3种微血管并发症。
  • 经多变量调整后,坚持4至5种低风险生活方式行为者相比0至1种者,糖尿病视网膜病变的风险比为0.65(95%CI 0.46-0.91),糖尿病肾病的风险比为0.43(95%CI 0.30-0.61),糖尿病神经病变的风险比为0.46(95%CI 0.29-0.74),复合结局的风险比为0.54(95%CI 0.43-0.68),所有趋势P值≤0.01。
  • 对整体健康生活方式依从性差(低风险因素<4种)的糖尿病微血管并发症的人群归因分数(95%CI)范围为25.3%(10.0%,39.4%)至39.0%(17.7%,56.8%)。
  • 白蛋白、高密度脂蛋白胆固醇、甘油三酯、载脂蛋白A、C反应蛋白和糖化血红蛋白共同解释了整体生活方式行为与总糖尿病微血管并发症之间关联的23.20%(12.70%,38.50%)。

局限性

  • 当前分析的关键局限性是微血管并发症可能被低估,因为病例是通过电子健康记录识别的。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The influence of overall lifestyle behaviors on diabetic microvascular complications remains unknown. In addition, the potential mediating biomarkers underlying the association is unclear. This study aimed to examine the associations of the combined lifestyle factors with risks of total and individual microvascular complications among patients with type 2 diabetes (T2D) and to explore the potential mediation effects of metabolic biomarkers. METHODS AND FINDINGS: This retrospective cohort study included 15,104 patients with T2D free of macro- and microvascular complications at baseline (2006 to 2010) from the UK Biobank. Healthy lifestyle behaviors included noncurrent smoking, recommended waist circumference, regular physical activity, healthy diet, and moderate alcohol drinking. Outcomes were ascertained using electronic health records. Over a median of 8.1 years of follow-up, 1,296 cases of the composite microvascular complications occurred, including 558 diabetic retinopathy, 625 diabetic kidney disease, and 315 diabetic neuropathy, with some patients having 2 or 3 microvascular complications simultaneously. After multivariable adjustment for sociodemographic characteristics, history of hypertension, glycemic control, and medication histories, the hazard ratios (95% confidence intervals (CIs)) for the participants adhering 4 to 5 low-risk lifestyle behaviors versus 0 to 1 were 0.65 (0.46, 0.91) for diabetic retinopathy, 0.43 (0.30, 0.61) for diabetic kidney disease, 0.46 (0.29, 0.74) for diabetic neuropathy, and 0.54 (0.43, 0.68) for the composite outcome (all Ps-trend ≤0.01). Further, the population-attributable fraction (95% CIs) of diabetic microvascular complications for poor adherence to the overall healthy lifestyle (<4 low-risk factors) ranged from 25.3% (10.0%, 39.4%) to 39.0% (17.7%, 56.8%). In addition, albumin, HDL-C, triglycerides, apolipoprotein A, C-reactive protein, and HbA1c collectively explained 23.20% (12.70%, 38.50%) of the associations between overall lifestyle behaviors and total diabetic microvascular complications. The key limitation of the current analysis was the potential underreporting of microvascular complications because the cases were identified via electronic health records. CONCLUSIONS: Adherence to overall healthy lifestyle behaviors was associated with a significantly lower risk of microvascular complications in patients with T2D, and the favorable associations were partially mediated through improving biomarkers of glycemic control, systemic inflammation, liver function, and lipid profile.

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Geng T, Zhu K, Lu Q, et al. Healthy lifestyle behaviors, mediating biomarkers, and risk of microvascular complications among individuals with type 2 diabetes: A cohort study. PLoS Med. 2023. PMID: 36626356. doi:10.1371/journal.pmed.1004135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。